Baidu
map

中国高血压防治指南(2018年修订版)

2019-01-09 中华中医药学会 心脑血管病防治.2019.19(1):1-44.

2018 年中国高血压防治指南修订参考了世界卫生组织、中华医学会指南制订流程,对指南重要内容、证据级别及推荐类型进行了评估。在借鉴国际先进经验的基础上,结合我国高血压防治工作实践,充分应用中国证据,形成具有中国特色的高血压预防干预、诊断评估、分类分层、治疗管理指南。

中文标题:

中国高血压防治指南(2018年修订版)

发布机构:

中华中医药学会

发布日期:

2019-01-09

简要介绍:

2018 年中国高血压防治指南修订参考了世界卫生组织、中华医学会指南制订流程,对指南重要内容、证据级别及推荐类型进行了评估。在借鉴国际先进经验的基础上,结合我国高血压防治工作实践,充分应用中国证据,形成具有中国特色的高血压预防干预、诊断评估、分类分层、治疗管理指南。 

拓展指南:高血压相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国高血压防治指南(2018年修订版))] GetToolGuiderByIdResponse(projectId=1, id=cd8381c00168885f, title=中国高血压防治指南(2018年修订版), enTitle=, guiderFrom=心脑血管病防治.2019.19(1):1-44., authorId=null, author=, summary=2018 年中国高血压防治指南修订参考了世界卫生组织、中华医学会指南制订流程,对指南重要内容、证据级别及推荐类型进行了评估。在借鉴国际先进经验的基础上,结合我国高血压防治工作实践,充分应用中国证据,形成具有中国特色的高血压预防干预、诊断评估、分类分层、治疗管理指南。 , cover=, journalId=null, articlesId=null, associationId=1618, associationName=中华中医药学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Jan 09 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2018 年中国高血压防治指南修订参考了世界卫生组织、中华医学会指南制订流程,对指南重要内容、证据级别及推荐类型进行了评估。在借鉴国际先进经验的基础上,结合我国高血压防治工作实践,充分应用中国证据,形成具有中国特色的高血压预防干预、诊断评估、分类分层、治疗管理指南。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>高血压</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=ffc2d1c001686ad4" title="2019 ACOG实践简报:妊娠期慢性高血压(No.203)" target=_blank>2019 ACOG实践简报:妊娠期慢性高血压(No.203)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=a385d1c001685e4f" title="2019 ACOG实践简报:妊娠高血压和先兆子痫(No.202)" target=_blank>2019 ACOG实践简报:妊娠高血压和先兆子痫(No.202)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c365e1c001663832" title="关于降压目标值的讨论——2017 美国高血压指南解读" target=_blank>关于降压目标值的讨论——2017 美国高血压指南解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=03a661c001663078" title="2018欧洲高血压防治指南解读" target=_blank>2018欧洲高血压防治指南解读</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c95af1c0016a13ea" title="2018 AHA科学声明:难治性高血压的检测,评估和管理" target=_blank>2018 AHA科学声明:难治性高血压的检测,评估和管理</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E9%AB%98%E8%A1%80%E5%8E%8B" target=_blank>有关高血压更多指南</a></ul>, tagList=[TagDto(tagId=9319, tagName=高血压防治)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17673, appHits=2337, showAppHits=54, pcHits=12654, showPcHits=4625, likes=157, shares=157, comments=8, approvalStatus=1, publishedTime=Tue Jan 15 20:28:10 CST 2019, publishedTimeString=2019-01-09, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 15 20:28:10 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:51:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国高血压防治指南(2018年修订版))])
中国高血压防治指南(2018年修订版)
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2234044, encodeId=fcee22340441e, content=这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=859e1989361, createdName=1e19f534m91(暂无匿称), createdTime=Wed Oct 30 00:36:29 CST 2024, time=2024-10-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1005077, encodeId=206d10050e75f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLTY24FbjhZYCiapjzb4fQtaibkeMfkB6numml4oUd7WetbXubAl6OKhK2ZmXBJUoWTd0Hw3fJZLwXA/132, createdBy=01dd2452180, createdName=金先森, createdTime=Wed Aug 04 10:53:40 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814176, encodeId=95b98141e65c, content=很好。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Thu Aug 27 18:02:23 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360407, encodeId=9c0e36040e76, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0fa2544582, createdName=1252b41am23(暂无昵称), createdTime=Mon Feb 11 17:20:00 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358241, encodeId=8631358241f3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 15 21:20:42 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2024-10-30 1e19f534m91(暂无匿称) 来自新疆

    这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2234044, encodeId=fcee22340441e, content=这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=859e1989361, createdName=1e19f534m91(暂无匿称), createdTime=Wed Oct 30 00:36:29 CST 2024, time=2024-10-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1005077, encodeId=206d10050e75f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLTY24FbjhZYCiapjzb4fQtaibkeMfkB6numml4oUd7WetbXubAl6OKhK2ZmXBJUoWTd0Hw3fJZLwXA/132, createdBy=01dd2452180, createdName=金先森, createdTime=Wed Aug 04 10:53:40 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814176, encodeId=95b98141e65c, content=很好。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Thu Aug 27 18:02:23 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360407, encodeId=9c0e36040e76, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0fa2544582, createdName=1252b41am23(暂无昵称), createdTime=Mon Feb 11 17:20:00 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358241, encodeId=8631358241f3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 15 21:20:42 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2021-08-04 金先森

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2234044, encodeId=fcee22340441e, content=这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=859e1989361, createdName=1e19f534m91(暂无匿称), createdTime=Wed Oct 30 00:36:29 CST 2024, time=2024-10-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1005077, encodeId=206d10050e75f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLTY24FbjhZYCiapjzb4fQtaibkeMfkB6numml4oUd7WetbXubAl6OKhK2ZmXBJUoWTd0Hw3fJZLwXA/132, createdBy=01dd2452180, createdName=金先森, createdTime=Wed Aug 04 10:53:40 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814176, encodeId=95b98141e65c, content=很好。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Thu Aug 27 18:02:23 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360407, encodeId=9c0e36040e76, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0fa2544582, createdName=1252b41am23(暂无昵称), createdTime=Mon Feb 11 17:20:00 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358241, encodeId=8631358241f3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 15 21:20:42 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2020-08-27 124794a3m20(暂无昵称)

    很好。。。。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2234044, encodeId=fcee22340441e, content=这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=859e1989361, createdName=1e19f534m91(暂无匿称), createdTime=Wed Oct 30 00:36:29 CST 2024, time=2024-10-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1005077, encodeId=206d10050e75f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLTY24FbjhZYCiapjzb4fQtaibkeMfkB6numml4oUd7WetbXubAl6OKhK2ZmXBJUoWTd0Hw3fJZLwXA/132, createdBy=01dd2452180, createdName=金先森, createdTime=Wed Aug 04 10:53:40 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814176, encodeId=95b98141e65c, content=很好。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Thu Aug 27 18:02:23 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360407, encodeId=9c0e36040e76, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0fa2544582, createdName=1252b41am23(暂无昵称), createdTime=Mon Feb 11 17:20:00 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358241, encodeId=8631358241f3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 15 21:20:42 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2019-02-11 1252b41am23(暂无昵称)

    不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2234044, encodeId=fcee22340441e, content=这份指南里证据是如何选择的?纳入了那些证据?证据体是如何评价的?详细的证据分级和推荐意见的形成过程始终看不到?用大量的篇幅介绍高血压的患病率水平和发病率水平。也许我理解有误。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=859e1989361, createdName=1e19f534m91(暂无匿称), createdTime=Wed Oct 30 00:36:29 CST 2024, time=2024-10-30, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=1005077, encodeId=206d10050e75f, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLTY24FbjhZYCiapjzb4fQtaibkeMfkB6numml4oUd7WetbXubAl6OKhK2ZmXBJUoWTd0Hw3fJZLwXA/132, createdBy=01dd2452180, createdName=金先森, createdTime=Wed Aug 04 10:53:40 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814176, encodeId=95b98141e65c, content=很好。。。。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1f4e2490464, createdName=124794a3m20(暂无昵称), createdTime=Thu Aug 27 18:02:23 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=360407, encodeId=9c0e36040e76, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0fa2544582, createdName=1252b41am23(暂无昵称), createdTime=Mon Feb 11 17:20:00 CST 2019, time=2019-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=358241, encodeId=8631358241f3, content=认真学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=159, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82311653708, createdName=医者仁心5538, createdTime=Tue Jan 15 21:20:42 CST 2019, time=2019-01-15, status=1, ipAttribution=)]
    2019-01-15 医者仁心5538

    认真学习

    0

Baidu
map
Baidu
map
Baidu
map